DSpace Repository

Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies

Show simple item record

dc.contributor.author Nijasri C. Suwanwela
dc.contributor.other Chulalongkorn University.Chulalongkorn Stroke Centre
dc.date.accessioned 2019-06-17T09:40:52Z
dc.date.available 2019-06-17T09:40:52Z
dc.date.issued 2018
dc.identifier.citation Cerebrovascular Diseases, Vol.46 , No.(1-2) (2018), p. 82-88. en_US
dc.identifier.issn 1015-9770
dc.identifier.uri http://cuir.car.chula.ac.th/handle/123456789/62135
dc.description.abstract MLC601 has been shown in preclinical studies to enhance neurorestorative mechanisms after stroke. The aim of this post hoc analysis was to assess whether combining MLC601 and rehabilitation has an effect on improving functional outcomes after stroke. Methods: Data from the CHInese Medicine NeuroAiD Efficacy on Stroke (CHIMES) and CHIMES-Extension (CHIMES-E) studies were analyzed. CHIMES-E was a 24-month follow-up study of subjects included in CHIMES, a multi-centre, double-blind placebo-controlled trial which randomized subjects with acute ischemic stroke, to either MLC601 or placebo for 3 months in addition to standard stroke treatment and rehabilitation. Subjects were stratified according to whether they received or did not receive persistent rehabilitation up to month (M)3 (non- randomized allocation) and by treatment group. The modified Rankin Scale (mRS) and Barthel Index were assessed at month (M) 3, M6, M12, M18, and M24. Results: Of 880 subjects in CHIMES-E, data on rehabilitation at M3 were available in 807 (91.7%, mean age 61.8 ± 11.3 years, 36% female). After adjusting for prognostic factors of poor outcome (age, sex, pre-stroke mRS, baseline National Institute of Health Stroke Scale, and stroke onset-to-study-treatment time), subjects who received persistent rehabilitation showed consistently higher treatment effect in favor of MLC601 for all time points on mRS 0–1 dichotomy analysis (ORs 1.85 at M3, 2.18 at M6, 2.42 at M12, 1.94 at M18, 1.87 at M24), mRS ordinal analysis (ORs 1.37 at M3, 1.40 at M6, 1.53 at M12, 1.50 at M18, 1.38 at M24), and BI ≥95 dichotomy analysis (ORs 1.39 at M3, 1.95 at M6, 1.56 at M12, 1.56 at M18, 1.46 at M24) compared to those who did not receive persistent rehabilitation. Conclusions: More subjects on MLC601 improved to functional independence compared to placebo among subjects receiving persistent rehabilitation up to M3. The larger treatment effect of MLC601 was sustained over 2 years which supports the hypothesis that MLC601 combined with rehabilitation might have beneficial and sustained effects on neuro-repair processes after stroke. There is a need for more data on the effect of combining rehabilitation programs with stroke recovery treatments. en_US
dc.language.iso en en_US
dc.publisher S. Karger AG en_US
dc.relation.uri https://www.karger.com/Article/FullText/492625
dc.relation.uri https://doi.org/10.1159/000492625
dc.rights © 2018 The Author(s) Published by S. Karger AG, Basel en_US
dc.title Effect of Combined Treatment with MLC601 (NeuroAiDTM) and Rehabilitation on Post-Stroke Recovery: The CHIMES and CHIMES-E Studies en_US
dc.type Article en_US
dc.subject.keyword Acute stroke en_US
dc.subject.keyword Stroke recovery en_US
dc.subject.keyword MLC601 en_US
dc.subject.keyword NeuroAiD en_US
dc.subject.keyword Rehabilitation en_US
dc.subject.keyword Combination en_US
dc.subject.keyword Clinical trial en_US
dc.subject.keyword Long-term outcome en_US
dc.identifier.DOI 10.1159/000492625


Files in this item

This item appears in the following Collection(s)

  • Foreign Journal Article [121]
    บทความวารสารภาษาต่างประเทศจากฐานข้อมูลออนไลน์ Free Open Access

Show simple item record